Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Moredun Foundation awards two honorary fellowships
David Danson and David Smith were individually recognised for their outstanding contributions to the Moredun Group.

Veterinary professionals recognised for outstanding contributions

Two honorary fellowships were awarded to both David Danson and David Smith at the AGM of the Moredun Foundation, the governing body of Moredun Research Institute.

David Danson has spent most of his career in industry, working as director of global marketing for Mallinckrodt Animal Health Inc in Chicago, as well as managing director, then chairman of Biokema SA in Lausanne. Between 1998 and 2005, he was group chief executive of UA Group.

Mr Danson is currently a non-executive director of Eco Animal Health Group, a council member of the RVC and chairman of RVC Developments. He joined the board of Moredun Scientific in 2000, making significant contributions towards the growth of the company until his departure in 2019.

Dr David Smith has dedicated much of his career to understanding worm infections in sheep. He recently made a major breakthrough in the treatment of worm infections in livestock by successfully developing a vaccine for Haemonchus contortus, the most prevalent worm affecting sheep and goats globally.

Dr Smith is also a director of Wormvax Australia, the commercial company set up to produce and distribute the vaccine in Australia. Work is currently ongoing to expand distribution of the vaccine to other countries.

Speaking at the AGM on Thursday 3 September, Ian Duncan Millar, chairman of the Moredun Foundation said: “It is a huge honour to be able to recognise the contribution of people who really have made a difference. This year’s recipients have done just that in very different ways. David Danson by being a board member of Moredun Scientific during a period of considerable growth in business and reputation.

“In a very different way David Smith has dedicated his life to the understanding of sheep gut worms, and his achievement in producing and marketing the first vaccine against one of these parasites is truly worthy of recognition, and a wonderful example of the excellence of our Moredun science and scientists.”

Image (c) Moredun Foundation.

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.